by Sébastien Guibert | 15 Jan 2019 | General news, Research
IMLINFO is a cross-border network of personalized immunotherapies for Non-Hodgkin’s lymphomas (NHL) involving 7 organizations located in Spain and France. Its main objective is to determine the efficacy of new immunotherapy treatments through the creation of a...
by Sébastien Guibert | 28 Aug 2018 | Publications, Research
Bétous, R., Goullet de Rugy, T., Pelegrini, A.L., Queille, S., de Villartay, J.-P., & Hoffmann, J.-S.*, 2018. DNA replication stress triggers Rapid DNA Replication Fork Breakage by Artemis and XPF. PLoS Genet. 14, e1007541. DNA replication stress (DRS) leads to...
by Sébastien Guibert | 3 Apr 2018 | General news, Research
Discover in this France 3 TV report the collaboration between the CRCT team led by Dr. Pierre Cordelier and the Toulouse start-up Neovirtech: a therapeutic innovation opening up new perspectives in the treatment of cancer....
by Sébastien Guibert | 22 Mar 2018 | General news, Research
Thanks to anticancer immunotherapies targeting immune checkpoints, the proportion of patients with metastatic melanoma (MM) in remission after 5 years has tripled during the last years. However, therapeutic options are sparse for patients who do not respond to...
by Sébastien Guibert | 29 Nov 2017 | Research
The program “PhD PI3K Biology in Health in Disease”, funded by the European Union (Horizon 2020 / Marie Sklodovska-Curie Program), aims to train the next generation of experts in the field of PI3Ks through the establishment of a European network of PhD...
